Related Experiment Video
Updated: Apr 9, 2026

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
Published on: March 3, 2021
Spastin-mediated severing of glutamylated microtubules controls cardiomyocyte coupling
Jiayin Zhang1,2,3,4, Xiaozhi Huang1,2,3, Zhichao Wu5
1Department of Cardiology, Center for Genetic Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.
Abstract:
Cardiac ischemia-reperfusion injury frequently induces malignant arrhythmias because of connexin 43 (Cx43) mislocalization and impaired cardiomyocyte coupling; yet, effective therapies targeting this mechanism remain scarce. Here we show that ischemic cardiomyopathy in humans and ischemia-reperfusion in mice promote the accumulation and stabilization of glutamylated microtubules, disrupting targeted Cx43 trafficking. This remodeling of the glutamylated microtubule network is mediated by the microtubule-severing enzyme spastin. Spastin overexpression in cardiomyocytes reduced microtubule density, whereas its deficiency caused accumulation of glutamylated, stabilized microtubules. Although cardiomyocyte-specific spastin knockout mice displayed normal cardiac structure and function at baseline, they were highly susceptible to stress-induced malignant arrhythmias. Mechanistically, spastin deficiency impaired microtubule plus end dynamics and Cx43 transport. Notably, genetic or pharmacological reduction of microtubule glutamylation before ischemia-reperfusion preserved Cx43 localization and mitigated oxidative stress-induced injury. Together, these findings identify microtubule glutamylation as a key regulator of cardiac electrical stability and a promising therapeutic target in ischemia-reperfusion injury.
Insights
Microtubule glutamylation disrupts connexin 43 (Cx43) trafficking, leading to arrhythmias during cardiac ischemia-reperfusion injury. Reducing glutamylation preserves Cx43 and mitigates injury, offering a new therapeutic target.
Area of Science:
- Cardiovascular Biology
- Cellular Biology
- Molecular Medicine
Background:
- Cardiac ischemia-reperfusion injury often causes malignant arrhythmias due to connexin 43 (Cx43) mislocalization and reduced cardiomyocyte coupling.
- Current therapies targeting these mechanisms are limited.
Purpose of the Study:
- To investigate the role of microtubule glutamylation in cardiac electrical stability during ischemia-reperfusion injury.
- To identify potential therapeutic targets for preventing arrhythmias.
Main Methods:
- Examined microtubule glutamylation and Cx43 trafficking in human ischemic cardiomyopathy and mouse models of ischemia-reperfusion.
- Utilized cardiomyocyte-specific spastin knockout mice to assess the impact of spastin deficiency on microtubule dynamics and Cx43 transport.
- Investigated the effects of genetic or pharmacological reduction of microtubule glutamylation before ischemia-reperfusion.
Main Results:
- Ischemia-reperfusion promotes accumulation and stabilization of glutamylated microtubules, disrupting Cx43 trafficking.
- Spastin deficiency leads to stabilized, glutamylated microtubules and impaired Cx43 transport, increasing susceptibility to arrhythmias.
- Reducing microtubule glutamylation preserved Cx43 localization and reduced oxidative stress-induced injury.
Conclusions:
- Microtubule glutamylation is a key regulator of cardiac electrical stability.
- Targeting microtubule glutamylation represents a promising therapeutic strategy for ischemia-reperfusion injury and associated arrhythmias.
Related Concept Videos
Microtubule Associated Proteins (MAPs)
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
Destabilization of Microtubules
Assembly of Complex Microtubule Structures
Microtubule Instability
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...

